Janus kinase/signal transducers and activator of transcription (JAK/STAT) and its role in Lung inflammatory disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Janus kinase/signal transducers and activator of transcription (JAK/STAT) and its role in Lung inflammatory disease
Authors
Keywords
-
Journal
CHEMICO-BIOLOGICAL INTERACTIONS
Volume 371, Issue -, Pages 110334
Publisher
Elsevier BV
Online
2023-01-05
DOI
10.1016/j.cbi.2023.110334
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach
- (2022) Yoshiya Tanaka et al. Nature Reviews Rheumatology
- JAK‐STAT core cancer pathway: An integrative cancer interactome analysis
- (2022) Fettah Erdogan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Recent Developments and Challenges in Molecular-Targeted Therapy of Non-Small-Cell Lung Cancer
- (2022) Suman Rohilla et al. JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY
- Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response
- (2021) Korneliusz Golebski et al. IMMUNITY
- Nuclear factor-kappa B and its role in inflammatory lung disease
- (2021) Khalid Saad Alharbi et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
- (2021) Paula Montero et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exposure interval to ambient fine particulate matter (PM2.5) collected in Southwest China induced pulmonary damage through the Janus tyrosine protein kinase‐2/signal transducer and activator of transcription‐3 signaling pathway both in vivo and in vitro
- (2021) Wuyang Yue et al. JOURNAL OF APPLIED TOXICOLOGY
- Surfactant protein A modulates the activities of the JAK/STAT pathway in suppressing Th1 and Th17 polarization in murine OVA-induced allergic asthma
- (2021) Xi Chen et al. LABORATORY INVESTIGATION
- STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology
- (2021) Georgia Karpathiou et al. PATHOLOGY RESEARCH AND PRACTICE
- Protein and peptide delivery to lungs by using advanced targeted drug delivery
- (2021) Dinesh Kumar Chellappan et al. CHEMICO-BIOLOGICAL INTERACTIONS
- JAK inhibitors for asthma
- (2021) Steve N. Georas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cigarette smoke-induced lung inflammation in COPD mediated via CCR1/JAK/STAT /NF-κB pathway
- (2020) Kaishun Zhao et al. Aging-US
- LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes
- (2020) Wenhan Yang et al. CARCINOGENESIS
- The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19
- (2020) Bakiye Goker Bagca et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn’s disease
- (2020) Friederike Cordes et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Panton-valentine leucocidin carrying Staphylococcus aureus causing necrotizing pneumonia inactivates the JAK/STAT signaling pathway and increases the expression of inflammatory cytokines
- (2020) Jing Huang et al. INFECTION GENETICS AND EVOLUTION
- Human gene expression profiling identifies key therapeutic targets in tuberculosis infection: A systematic network meta-analysis
- (2020) Aftab Alam et al. INFECTION GENETICS AND EVOLUTION
- JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy
- (2020) Sairaj Satarker et al. POSTGRADUATE MEDICINE
- A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection
- (2020) Firoz Ahmed Frontiers in Immunology
- JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models
- (2019) Manish R. Patel et al. CANCER GENE THERAPY
- JNK signaling in cancer cell survival
- (2019) Qinghua Wu et al. MEDICINAL RESEARCH REVIEWS
- Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway
- (2019) Mingjing Shen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The effect of astragaloside IV on JAK2‐STAT6 signalling pathway in mouse model of ovalbumin‐induced asthma
- (2019) Xinfu Yang et al. JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION
- JAK–STAT inhibition impairs K‐RAS‐driven lung adenocarcinoma progression
- (2019) Julian Mohrherr et al. INTERNATIONAL JOURNAL OF CANCER
- Surfactant protein C dampens inflammation by decreasing JAK/STAT activation during lung repair
- (2018) Huiyan Jin et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- LPS Exposure in Early Life Protects Against Mucus Hypersecretion in Ovalbumin-Induced Asthma by Down-Regulation of the IL-13 and JAK-STAT6 Pathways
- (2018) Fengxia Ding et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Astragaloside IV Inhibits Cigarette Smoke-Induced Pulmonary Inflammation in Mice
- (2018) Zhou Meiqian et al. INFLAMMATION
- Coronavirus TGEV Evades the Type I Interferon Response through IRE1α-Mediated Manipulation of the miR-30a-5p/SOCS1/3 Axis
- (2018) Yanlong Ma et al. JOURNAL OF VIROLOGY
- JAK inhibitors in dermatology: The promise of a new drug class
- (2017) William Damsky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Inflammatory responses and inflammation-associated diseases in organs
- (2017) Linlin Chen et al. Oncotarget
- Eriobotrya japonica Water Extract Characterization: An Inducer of Interferon-Gamma Production Mainly by the JAK-STAT Pathway
- (2016) Khalid Matalka et al. MOLECULES
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- JAK–STAT pathway activation in COPD
- (2015) Liang Yew-Booth et al. EUROPEAN RESPIRATORY JOURNAL
- The Specific Roles of JAK/STAT Signaling Pathway in Sepsis
- (2015) Bin Cai et al. INFLAMMATION
- Biology of IL-27 and its Role in the Host Immunity against Mycobacterium Tuberculosis
- (2015) Abualgasim Elgaili Abdalla et al. International Journal of Biological Sciences
- Retinoic acid amide inhibits JAK/STAT pathway in lung cancer which leads to apoptosis
- (2015) Hong-Xing Li et al. TUMOR BIOLOGY
- Protective Effects of Astragaloside IV against Ovalbumin-Induced Lung Inflammation Are Regulated/Mediated by T-bet/GATA-3
- (2014) Yu-Ying Qiu et al. PHARMACOLOGY
- Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors
- (2013) Saul Jaime-Figueroa et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Chronic Bronchitis and Chronic Obstructive Pulmonary Disease
- (2012) Victor Kim et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The CFP-10/ESAT-6 complex of Mycobacterium tuberculosis potentiates the activation of murine macrophages involvement of IFN-γ signaling
- (2010) Si Guo et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started